Journal

Nature

Publication Date

6-1-2022

Volume

606

Issue

7913

First Page

343

Last Page

350

Document Type

Open Access Publication

DOI

10.1038/s41586-022-04786-y

41586_2022_4786_MOESM1_ESM.pdf (4599 kB)
Supplementary Information

41586_2022_4786_MOESM2_ESM.pdf (2749 kB)
Reporting Summary

41586_2022_4786_MOESM3_ESM.pdf (1996 kB)
Peer Review File

41586_2022_4786_MOESM4_ESM.zip (81549 kB)
Supplementary Data - HTMLs of notebooks outlining key statistical analyses presented in the manuscript, including analysis of phylogenetic trees

41586_2022_4786_MOESM5_ESM.xlsx (9 kB)
Supplementary Table 1 - Demographic data and clinical details for donors used in the study

41586_2022_4786_MOESM6_ESM.xlsx (9 kB)
Supplementary Table 2 - Details of antibodies used for flow cytometry in the study

41586_2022_4786_MOESM7_ESM.xlsx (35 kB)
Supplementary Table 3 - Structural variants observed in the dataset

41586_2022_4786_MOESM8_ESM.xlsx (19 kB)
Supplementary Table 4 - Genes used as known clonal haematopoiesis, myeloid malignancy genes or cancer genes

41586_2022_4786_MOESM9_ESM.xlsx (29 kB)
Supplementary Table 5 - Variants identified in known myeloid genes in the dataset

41586_2022_4786_MOESM10_ESM.xlsx (205 kB)
Supplementary Table 6 - Results of dNdScv analysis for the top 1500 genes with most significant mutation burdens

41586_2022_4786_MOESM11_ESM.xlsx (3273 kB)
Supplementary Table 7 - Coding variants observed in the study

41586_2022_4786_MOESM12_ESM.xlsx (10 kB)
Supplementary Table 8 - Variants observed in ZNF318 and HIST2H3D in our dataset

41586_2022_4786_MOESM13_ESM.xlsx (11 kB)
Supplementary Table 9 - Variants in ZNF318 and HIST2H3D seen in 534 AML genomes

Share

COinS